Related Experiment Videos

Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis

T Senderovitz¹, B G Skov, F R Hirsch

¹Medical Department P, Bispebjerg Hospital, Copenhagen, Denmark.

Cancer Treatment and Research

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026

Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Lung cancer research and treatment: global perspectives and strategic calls to action.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Consensus for HER2 alterations testing in non-small-cell lung cancer.

ESMO open·2022

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib.

Lung cancer (Amsterdam, Netherlands)·2019

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

See all related articles